Why I'd Still Buy This 10%-Yielding Dividend Stock After the Fed's Latest Hike

The Fed raised the federal-funds target range 25bps to 3.75%-4.00% amid inflation above 3%, and markets expect additional hikes later this year. Higher rates pressure Ares Capital's valuation and borrowing costs, with $11.8B, or 74%, of its $15.9B debt floating-rate; shares are nearly 10% below their high and yield more than 10%. However, 71% of Ares' $29.3B portfolio is floating-rate, and 94% of its $2.6B of Q2 new commitments were floating-rate, positioning higher investment income to more than offset funding-cost pressure.

Analysis

The relevant question is not gross floating-rate assets versus liabilities, but net investment income sensitivity after borrower rate floors, hedges, unused revolver capacity, and incentive-fee sharing. Incremental benchmark-rate income initially supports coverage, but the benefit diminishes once portfolio-company interest burdens breach cash-flow capacity; at that point, non-accruals, PIK income, and NAV marks matter far more than the coupon uplift. This makes the next quarterly portfolio-quality disclosure more consequential than another 25 bp policy move.

ARCC's scale and sponsor relationships should improve lender selectivity as banks retrench and weaker private-credit platforms compete less aggressively. That can widen new-loan spreads and improve documentation over the next 6-18 months, while smaller/lower-quality BDCs such as FSK face greater downside if refinancing conditions tighten. The near-term risk is valuation: a 10% cash yield is not a floor if investors demand a wider credit-risk premium, and BDC discounts can widen rapidly when non-accruals rise even while reported NII remains intact.

Consensus is likely overfocusing on dividend coverage and underweighting delayed credit transmission. Private borrowers typically absorb higher debt service with a lag through covenant amendments, sponsor equity cures, or PIK elections, so a superficially strong 1-3 month NII print could precede weaker realized-credit performance in 2027. A constructive ARCC view is warranted only if non-accruals remain contained, NAV is stable, and new-originations retain attractive spreads rather than merely expanding volume.

Key Decisions for Investors

• Do not add outright ARCC solely on the rate move; wait for the next earnings release to confirm stable NAV per share, non-accruals, and regular-dividend coverage. Treat a meaningful NAV decline or rising PIK/non-accrual exposure as thesis failure regardless of NII growth.
• Express relative quality rather than broad BDC beta: long ARCC / short FSK over a 3-6 month horizon, sized dollar-neutral. The trade captures ARCC's scale and underwriting advantage if credit dispersion widens; exit if FSK's credit metrics converge or ARCC's NAV deterioration exceeds peers.
• For income exposure, accumulate ARCC only at a discount to reported NAV or after a post-earnings credit-quality confirmation, rather than chasing the stated cash yield. Risk/reward improves materially if the market prices a recession-level discount without corresponding non-accrual deterioration.
• Monitor BIZD as the sector-risk hedge and watch private-credit stress indicators: ARCC non-accruals, PIK income, realized losses, and sponsor-backed middle-market default trends. If these deteriorate for two consecutive quarters, reduce BDC exposure despite higher nominal dividends.